ClearBridge Investments Global Growth Strategy Q1 2022 Commentary
During the first quarter, the ClearBridge Global Growth Strategy underperformed its MSCI ACWI benchmark. Click here to read the full fund letter.
Stay updated with breaking news from Kodiak Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
During the first quarter, the ClearBridge Global Growth Strategy underperformed its MSCI ACWI benchmark. Click here to read the full fund letter.
We have referred to quarterly return data to come up with five best performing small-cap stocks in Q1 2022 and worst performing small-cap stocks in Q1 2022.
Kodiak Sciences (NASDAQ:KOD – Get Rating)‘s stock had its “buy” rating reiterated by equities research analysts at Chardan Capital in a note issued to investors on Monday, Zacks.com reports. Other equities research analysts have also recently issued research reports about the company. Barclays dropped their price objective on Kodiak Sciences from $81.00 to $50.00 and […]
Kodiak Sciences (NASDAQ:KOD – Get Rating) had its price target cut by Morgan Stanley from $17.00 to $12.00 in a report issued on Tuesday, MarketBeat reports. They currently have an equal weight rating on the stock. Several other analysts have also recently issued reports on KOD. JPMorgan Chase & Co. cut Kodiak Sciences from an […]
Analysts expect Kodiak Sciences Inc. (NASDAQ:KOD – Get Rating) to post earnings per share of ($1.47) for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Kodiak Sciences’ earnings. The highest EPS estimate is ($0.73) and the lowest is ($1.80). Kodiak Sciences reported earnings per share of ($0.98) during the […]